This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Sherry Y Wu: Innovator in RNAi Therapeutics Delivery
Introduction
Sherry Y Wu is a prominent inventor based in Houston, Texas. She has made significant contributions to the field of RNA interference (RNAi) therapeutics through her innovative work in nanoparticle technology. Her research focuses on developing advanced delivery systems for therapeutic agents, which can potentially transform treatment methodologies.
Latest Patents
Sherry Y Wu holds a patent for a "Hybrid exosomal-polymeric (hexpo) nano-platform for delivery of RNAi therapeutics." This invention involves lipid-based nanoparticles, specifically exosomes, that feature a core made of a cationic polymer and a therapeutic agent. The lipid coating comprises an exosome-derived membrane, enhancing the delivery of various therapeutic agents, including proteins, antibodies, inhibitory RNA, and small molecule drugs. The patent also outlines methods for producing these nanoparticles and their therapeutic applications.
Career Highlights
Wu is affiliated with the University of Texas System, where she continues her research and development in the field of nanomedicine. Her work has garnered attention for its potential to improve the efficacy of RNAi therapeutics, making her a key figure in this innovative area of study.
Collaborations
Sherry Y Wu collaborates with esteemed colleagues such as Gabriel Lopez-Berestein and Anil K Sood. These partnerships enhance her research capabilities and contribute to the advancement of therapeutic technologies.
Conclusion
Sherry Y Wu's contributions to RNAi therapeutics through her innovative nanoparticle technology highlight her role as a leading inventor in the field. Her work promises to pave the way for new treatment options and improved patient outcomes.